Kyle Bass Convinces PTAB To Review Citius Drug Patent
The Patent Trial and Appeal Board on Friday granted hedge fund manager Kyle Bass and self-described "patent troll" Erich Spangenberg's request to review claims in Citius Pharmaceuticals Inc.'s obesity drug Suprenza,...To view the full article, register now.
Already a subscriber? Click here to view full article